Stable crystalline and solid formulations of sedatives and nasal blockers containing non sedatives

摘要

It refers to a drug synthesis, including: (a) chlortadine from 0.4 mg / ml to 0.7 mg / ml; (b) pseudoephedrine, propanolamine and other nasal blocking agents;(c) Such as ambroxol and (d) pharmaceutically acceptable projectors. Ingredients include an antibacterial agent, a sweetener, propylene glycol and glycerin. It also refers to a stable soluble pharmacological composition, including: (a) a sweetener, such as an adsorbent, extracted from sodium; (b) a liquid vehicle; and (c) a buffer system that maintains a pH value of 3-5. Stable microbial contamination at ambient temperature of 4 to 36 months